4//SEC Filing
Bass James Edward 4
Accession 0001209191-18-037674
CIK 0001358762other
Filed
Jun 13, 8:00 PM ET
Accepted
Jun 14, 2:24 PM ET
Size
8.0 KB
Accession
0001209191-18-037674
Insider Transaction Report
Form 4
Bass James Edward
Director
Transactions
- Award
Stock Option (right to buy)
2018-06-13+8,000→ 8,000 totalExercise: $39.48Exp: 2028-06-13→ Class B common stock (8,000 underlying) - Award
Stock Option (right to buy)
2018-06-13$26.49/sh+693$18,358→ 693 totalExercise: $39.48Exp: 2028-06-13→ Class B common stock (693 underlying)
Footnotes (3)
- [F1]The options vest in 4 equal installments on September 13, 2018, December 13, 2018, March 13, 2019, and June 13, 2019, subject to continued service through each vesting date.
- [F2]The Class B common stock is convertible into Class A common stock on a one-for-one basis at the holder's election at any time. The conversion right of the Class B common stock has no expiration date.
- [F3]This option was issued to the reporting person pursuant to the Reata Non-Employee Director Compensation Policy in lieu of future director fees of $18,375.00
Documents
Issuer
REATA PHARMACEUTICALS INC
CIK 0001358762
Entity typeother
Related Parties
1- filerCIK 0001662321
Filing Metadata
- Form type
- 4
- Filed
- Jun 13, 8:00 PM ET
- Accepted
- Jun 14, 2:24 PM ET
- Size
- 8.0 KB